For example, in patients with lung cancer, higher FZD2 expression was associated with improved survival; also, in patients with high-grade serous carcinoma after chemotherapy, the high level of FZD1 was associated with longer OS (31, 32). Here, FZD2 is linked to serous adenocarcinoma.